According to the famous Wisconsin Cohort Sleep Study , a 10% weight gain resulted in a 32% increase in participants AHI scores, plus they were also 6 times more likely to develop moderate to severe OSA
While this appetite suppression drives weight loss, eating substantially below your body's caloric needs triggers a cascade of metabolic stress that undermines your health and treatment goals
Hypoglycemic Drugs Insulin Secretagogues Sulfonylureas 1st Generation Sulfonylureas: Tolbutamide & Chlorpropamide RARELY PRESCRIBED (lower potency, greater toxicity) Trade Names: Tolbutamide (Orinase , Oramide ) Chlorpropamide (Diabinese ) Drug Class: oral hypoglycemic, sulfonylurea, first generation The use of 1st generation drugs has been replaced by newer generation sulfonylureas (mentioned here for historical purpose only) Keywords 2nd Generation Sulfonylureas: Glimepiride, Glipizide & Glyburide Fewer drug interactions, & side effects, more commonly prescribed Drugs & Trade Names: Glimepiride (Amaryl ) Glipizide (Glucotrol , Glucotrol XL ) Glyburide (DiaBeta , Micronase ) Drug Class: oral hypoglycemic, sulfonylurea, second generation Mechanism of Action: blocks ATP-regulated K channels causing depolarization that results in Ca influx and enhanced insulin release from pancreatic -cells (see Figure 1 in Beta Cell Pharmacology)
The FDA has also cautioned that compounded GLP-1s are not FDA-approved, may have inconsistent dosing and could pose safety risks
GLP1 hair loss often improves once the trigger stabilizes, but visible regrowth still takes months
